TransMedics names new CFO and reiterates 2026 revenue guidance

Go back to TransMedics names new CFO and reiterates 2026 revenue guidance
(NASDAQ: TMDX) Delayed: 85.04 --0 (-0%)
Previous Close $85.04    52 Week High
Open $85.04    52 Week Low
Day High $85.04    P/E N/A 
Day Low $85.04    EPS
Volume 627